SNP marker relevant to asthma pathogenesis risk factor and application of SNP marker
A technology for risk and asthma, which is applied in the application field of preparing a diagnostic reagent for the risk of asthma onset, can solve problems such as unclear genetic patterns, and achieve the effects of being beneficial to clinical promotion, low cost, and low equipment requirements.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0029] 1. Research object
[0030] From January 2011 to May 2013, 462 adult patients with asthma were continuously recruited in the Respiratory Clinic of the Second Affiliated Changzhou Hospital of Nanjing Medical University. The control group was 398 healthy people with no family history of atopy and asthma and normal lung function.
[0031] Asthma was diagnosed according to the 2010 edition of the Global Initiative for Asthma Prevention and Control Initiative diagnostic criteria and divided into intermittent attacks (level 1), mild persistent (level 2), moderate persistent (level 3), and severe persistent (level 4) according to severity. All patients with asthma have a history of asthma for at least one year and meet one of the following criteria: ①Peak expiratory flow (PEF)≥20%; ②FEV1 increases ≥12% after inhaling a short-acting β2 receptor agonist for 10 to 20 minutes, and absolute Value ≥ 200ml; ③ 5 to 15 minutes after exercise, FEV1 decreased by ≥ 15% or PEF decreased b...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com